Teva Pharmaceutical Industries Ltd.

05/17/2022 | Press release | Distributed by Public on 05/17/2022 05:49

Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges